If you are a qualified healthcare professional, you can access medicines available
through the pre-approval access programs (also known as early access, expanded access,
named patient, compassionate use and managed access)
Inceptua is running in partnership with pharmaceutical clients.
Inceptua is supporting a large number of pharmaceutical and biotech companies, through its management of pre-approval access programs for their assets.
Currently Inceptua is managing programs covering a wide range of rare disease products, oncology products and infectious disease products, allowing physicians to access these medicines prior to their commercial approval.
The full list of ongoing pre-approval access programs being managed by Inceptua, along with their inclusion criteria, and geographic scope, can be viewed by registering with our IMAP portal
SUPPORTING YOU THROUGH THE ENTIRE PROCESS